Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourBearish
15 minStrong Bearish
5 minExpanding
Daily trend turns up above $41.53
Key levels
Resistance$41.53
Resistance$2.35
Support$0.36
Latest news & SEC filings
No headlines in the last 90 days.
Jaguar Health is a prescription drug company that develops plant-derived treatments for gastrointestinal conditions. Its main product, Mytesi, is approved to ease diarrhea in HIV/AIDS patients receiving antiretroviral therapy, and it also markets Gelclair for oral mucositis pain. The company develops crofelemer-based therapies for rare intestinal failure disorders and, through a joint venture, for mental health conditions. It operates in the United States and Europe and also develops gastrointestinal products for dogs.
Based on the company's 10-K filed Apr 7, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for JAGX.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
PEG
Fair Value
$-0.06
15
Moat Score
NONE
2/9
Piotroski Score
-18.9
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-1.5%
3yr Revenue CAGR
-1.3%
EPS Growth YoY
82.42%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for JAGX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:56:43 | $0.44 | 1,568 | $$683 | BUY |
| 15:56:20 | $0.43 | 1,644 | $$713 | BUY |
| 15:50:52 | $0.44 | 9,000 | $$4K | BUY |
| 15:49:21 | $0.42 | 1,198 | $$509 | SELL |
| 15:43:28 | $0.44 | 2,200 | $$975 | BUY |
5 dark pool trades shown · $$7K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Jaguar Health, Inc. (JAGX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Jaguar Health, Inc. (JAGX) is at $0.44, down 8.64% (-$0.04) at the Nov 12, 2026 close.
JAGX last reported on Aug 19, 2026: EPS -$2.35 vs -$7.82 expected — a beat of 69.9%.
JAGX trades at a P/E of 0.0 vs a Healthcare average of 17.7.
JAGX does not currently pay a dividend.
Support: $0.36. Resistance: $2.35, $41.53, $70875000.00.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.